ID   HIPK3_HUMAN             Reviewed;        1215 AA.
AC   Q9H422; O14632; Q2PBG4; Q2PBG5; Q92632; Q9HAS2;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Homeodomain-interacting protein kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Androgen receptor-interacting nuclear protein kinase;
DE            Short=ANPK;
DE   AltName: Full=Fas-interacting serine/threonine-protein kinase;
DE            Short=FIST;
DE   AltName: Full=Homolog of protein kinase YAK1;
GN   Name=HIPK3; Synonyms=DYRK6, FIST3, PKY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9373137; DOI=10.1016/S0378-1119(97)00350-8;
RA   Begley D.A., Berkenpas M.B., Sampson K.E., Abraham I.;
RT   "Identification and sequence of human PKY, a putative kinase with
RT   increased expression in multidrug-resistant cells, with homology to
RT   yeast protein kinase Yak1.";
RL   Gene 200:35-43(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11034606; DOI=10.1084/jem.192.8.1165;
RA   Rochat-Steiner V., Becker K., Micheau O., Schneider P., Burns K.,
RA   Tschopp J.;
RT   "FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that
RT   induces FADD phosphorylation and inhibits Fas-mediated Jun NH2-
RT   terminal kinase activation.";
RL   J. Exp. Med. 192:1165-1174(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-295 (ISOFORMS 1/2).
RA   Becker W., Joost H.G.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9725910; DOI=10.1091/mbc.9.9.2527;
RA   Moilanen A.-M., Karvonen U., Poukka H., Jaenne O.A., Palvimo J.J.;
RT   "Activation of androgen receptor function by a novel nuclear protein
RT   kinase.";
RL   Mol. Biol. Cell 9:2527-2543(1998).
RN   [6]
RP   INTERACTION WITH UBL1.
RX   PubMed=10961991; DOI=10.1074/jbc.M004293200;
RA   Minty A., Dumont X., Kaghad M., Caput D.;
RT   "Covalent modification of p73alpha by SUMO-1. Two-hybrid screening
RT   with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1
RT   interaction motif.";
RL   J. Biol. Chem. 275:36316-36323(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=14766760; DOI=10.1074/jbc.M307629200;
RA   Curtin J.F., Cotter T.G.;
RT   "JNK regulates HIPK3 expression and promotes resistance to Fas-
RT   mediated apoptosis in DU 145 prostate carcinoma cells.";
RL   J. Biol. Chem. 279:17090-17100(2004).
RN   [8]
RP   FUNCTION AS KINASE AND IN CAMP SIGNALING PATHWAY, INTERACTION WITH
RP   NR5A1/SF1, AND MUTAGENESIS OF LYS-226.
RX   PubMed=17210646; DOI=10.1128/MCB.02253-06;
RA   Lan H.-C., Li H.-J., Lin G., Lai P.-Y., Chung B.-C.;
RT   "Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through
RT   homeodomain-interacting protein kinase 3-mediated Jun N-terminal
RT   kinase and c-Jun phosphorylation.";
RL   Mol. Cell. Biol. 27:2027-2036(2007).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-142; GLU-170; ARG-191; ASN-500 AND
RP   LEU-729.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in
CC       transcription regulation, apoptosis and steroidogenic gene
CC       expression. Phosphorylates JUN and RUNX2. Seems to negatively
CC       regulate apoptosis by promoting FADD phosphorylation. Enhances
CC       androgen receptor-mediated transcription. May act as a
CC       transcriptional corepressor for NK homeodomain transcription
CC       factors. The phosphorylation of NR5A1 activates SF1 leading to
CC       increased steroidogenic gene expression upon cAMP signaling
CC       pathway stimulation. In osteoblasts, supports transcription
CC       activation: phosphorylates RUNX2 that synergizes with SPEN/MINT to
CC       enhance FGFR2-mediated activation of the osteocalcin FGF-
CC       responsive element (OCFRE). {ECO:0000269|PubMed:14766760,
CC       ECO:0000269|PubMed:17210646}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with Nkx1-2. Interacts with FAS and DAXX.
CC       Probably part of a complex consisting of HIPK3, FAS and FADD.
CC       Interacts with and stabilizes ligand-bound androgen receptor (AR)
CC       (By similarity). Interacts with UBL1/SUMO-1. Binds to NR5A1/SF1,
CC       SPEN/MINT and RUNX2. {ECO:0000250, ECO:0000269|PubMed:10961991,
CC       ECO:0000269|PubMed:17210646}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11034606}.
CC       Nucleus {ECO:0000269|PubMed:11034606}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HIPK3;
CC         IsoId=Q9H422-1; Sequence=Displayed;
CC       Name=2; Synonyms=FIST;
CC         IsoId=Q9H422-2; Sequence=VSP_013140;
CC   -!- TISSUE SPECIFICITY: Overexpressed in multidrug resistant cells.
CC       Highly expressed in heart and skeletal muscle, and at lower levels
CC       in placenta, pancreas, brain, spleen, prostate, thymus, testis,
CC       small intestine, colon and leukocytes. Not found in liver and
CC       lung. {ECO:0000269|PubMed:11034606, ECO:0000269|PubMed:9373137,
CC       ECO:0000269|PubMed:9725910}.
CC   -!- PTM: Autophosphorylated, but autophosphorylation is not required
CC       for catalytic activity. {ECO:0000250}.
CC   -!- PTM: May be sumoylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. HIPK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF004849; AAC64294.1; -; mRNA.
DR   EMBL; AF305239; AAG25990.1; -; mRNA.
DR   EMBL; AL122015; CAC13164.1; -; Genomic_DNA.
DR   EMBL; AL122015; CAJ55828.1; -; Genomic_DNA.
DR   EMBL; Y09306; CAA70489.1; ALT_TERM; mRNA.
DR   CCDS; CCDS41634.1; -. [Q9H422-2]
DR   CCDS; CCDS7884.1; -. [Q9H422-1]
DR   RefSeq; NP_001041665.1; NM_001048200.2. [Q9H422-2]
DR   RefSeq; NP_001265092.1; NM_001278163.1. [Q9H422-2]
DR   RefSeq; NP_005725.3; NM_005734.4. [Q9H422-1]
DR   RefSeq; XP_005252786.1; XM_005252729.2. [Q9H422-1]
DR   RefSeq; XP_016872565.1; XM_017017076.1. [Q9H422-1]
DR   RefSeq; XP_016872566.1; XM_017017077.1. [Q9H422-2]
DR   UniGene; Hs.201918; -.
DR   UniGene; Hs.709696; -.
DR   ProteinModelPortal; Q9H422; -.
DR   BioGrid; 115420; 30.
DR   IntAct; Q9H422; 22.
DR   MINT; MINT-1183373; -.
DR   STRING; 9606.ENSP00000304226; -.
DR   BindingDB; Q9H422; -.
DR   ChEMBL; CHEMBL4577; -.
DR   GuidetoPHARMACOLOGY; 2035; -.
DR   iPTMnet; Q9H422; -.
DR   PhosphoSitePlus; Q9H422; -.
DR   DMDM; 61213741; -.
DR   EPD; Q9H422; -.
DR   MaxQB; Q9H422; -.
DR   PaxDb; Q9H422; -.
DR   PeptideAtlas; Q9H422; -.
DR   PRIDE; Q9H422; -.
DR   DNASU; 10114; -.
DR   Ensembl; ENST00000303296; ENSP00000304226; ENSG00000110422. [Q9H422-1]
DR   Ensembl; ENST00000379016; ENSP00000368301; ENSG00000110422. [Q9H422-2]
DR   Ensembl; ENST00000456517; ENSP00000398241; ENSG00000110422. [Q9H422-2]
DR   Ensembl; ENST00000525975; ENSP00000431710; ENSG00000110422. [Q9H422-2]
DR   GeneID; 10114; -.
DR   KEGG; hsa:10114; -.
DR   UCSC; uc001mul.3; human. [Q9H422-1]
DR   CTD; 10114; -.
DR   DisGeNET; 10114; -.
DR   GeneCards; HIPK3; -.
DR   HGNC; HGNC:4915; HIPK3.
DR   HPA; HPA028069; -.
DR   MIM; 604424; gene.
DR   neXtProt; NX_Q9H422; -.
DR   OpenTargets; ENSG00000110422; -.
DR   PharmGKB; PA29292; -.
DR   eggNOG; KOG0667; Eukaryota.
DR   eggNOG; ENOG410XPET; LUCA.
DR   GeneTree; ENSGT00760000119032; -.
DR   HOGENOM; HOG000231785; -.
DR   HOVERGEN; HBG051908; -.
DR   InParanoid; Q9H422; -.
DR   KO; K08826; -.
DR   OMA; PAMLQTN; -.
DR   OrthoDB; EOG091G0UMX; -.
DR   PhylomeDB; Q9H422; -.
DR   TreeFam; TF105417; -.
DR   SignaLink; Q9H422; -.
DR   SIGNOR; Q9H422; -.
DR   ChiTaRS; HIPK3; human.
DR   GeneWiki; HIPK3; -.
DR   GenomeRNAi; 10114; -.
DR   PRO; PR:Q9H422; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110422; -.
DR   CleanEx; HS_HIPK3; -.
DR   ExpressionAtlas; Q9H422; baseline and differential.
DR   Genevisible; Q9H422; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016605; C:PML body; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0009299; P:mRNA transcription; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043508; P:negative regulation of JUN kinase activity; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Complete proteome;
KW   Cytoplasm; Isopeptide bond; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN         1   1215       Homeodomain-interacting protein kinase 3.
FT                                /FTId=PRO_0000085998.
FT   DOMAIN      197    525       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     203    211       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      767    944       Interaction with AR. {ECO:0000250}.
FT   REGION      796    891       Interaction with FAS. {ECO:0000250}.
FT   REGION      855   1011       Required for localization to nuclear
FT                                speckles. {ECO:0000250}.
FT   REGION      866    918       SUMO interaction motifs (SIM); required
FT                                for nuclear localization and kinase
FT                                activity. {ECO:0000250}.
FT   REGION      870    880       Interaction with UBL1. {ECO:0000305}.
FT   COMPBIAS    910    962       Ser-rich.
FT   ACT_SITE    322    322       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     226    226       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     359    359       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9ERH7}.
FT   CROSSLNK     27     27       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   CROSSLNK   1208   1208       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   VAR_SEQ     770    790       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11034606}.
FT                                /FTId=VSP_013140.
FT   VARIANT     142    142       Q -> R (in dbSNP:rs34193811).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040549.
FT   VARIANT     170    170       G -> E (in dbSNP:rs34698015).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040550.
FT   VARIANT     191    191       C -> R (in dbSNP:rs35689361).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040551.
FT   VARIANT     474    474       V -> I (in dbSNP:rs266472).
FT                                /FTId=VAR_051627.
FT   VARIANT     500    500       S -> N (in dbSNP:rs11032229).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040552.
FT   VARIANT     729    729       P -> L (in dbSNP:rs55807239).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040553.
FT   MUTAGEN     226    226       K->R: Loss of kinase activity and
FT                                impaired activation of SF1.
FT                                {ECO:0000269|PubMed:17210646}.
FT   CONFLICT     69     69       N -> K (in Ref. 2; AAG25990).
FT                                {ECO:0000305}.
FT   CONFLICT    111    111       A -> V (in Ref. 1; AAC64294).
FT                                {ECO:0000305}.
FT   CONFLICT   1148   1148       Q -> K (in Ref. 2; AAG25990).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1215 AA;  133743 MW;  E952D04786955721 CRC64;
     MASQVLVYPP YVYQTQSSAF CSVKKLKVEP SSCVFQERNY PRTYVNGRNF GNSHPPTKGS
     AFQTKIPFNR PRGHNFSLQT SAVVLKNTAG ATKVIAAQAQ QAHVQAPQIG AWRNRLHFLE
     GPQRCGLKRK SEELDNHSSA MQIVDELSIL PAMLQTNMGN PVTVVTATTG SKQNCTTGEG
     DYQLVQHEVL CSMKNTYEVL DFLGRGTFGQ VVKCWKRGTN EIVAIKILKN HPSYARQGQI
     EVSILARLST ENADEYNFVR AYECFQHRNH TCLVFEMLEQ NLYDFLKQNK FSPLPLKVIR
     PILQQVATAL KKLKSLGLIH ADLKPENIML VDPVRQPYRV KVIDFGSASH VSKTVCSTYL
     QSRYYRAPEI ILGLPFCEAI DMWSLGCVIA ELFLGWPLYP GALEYDQIRY ISQTQGLPGE
     QLLNVGTKST RFFCKETDMS HSGWRLKTLE EHEAETGMKS KEARKYIFNS LDDVAHVNTV
     MDLEGSDLLA EKADRREFVS LLKKMLLIDA DLRITPAETL NHPFVNMKHL LDFPHSNHVK
     SCFHIMDICK SHLNSCDTNN HNKTSLLRPV ASSSTATLTA NFTKIGTLRS QALTTSAHSV
     VHHGIPLQAG TAQFGCGDAF QQTLIICPPA IQGIPATHGK PTSYSIRVDN TVPLVTQAPA
     VQPLQIRPGV LSQTWSGRTQ QMLVPAWQQV TPLAPATTTL TSESVAGSHR LGDWGKMISC
     SNHYNSVMPQ PLLTNQITLS APQPVSVGIA HVVWPQPATT KKNKQCQNRG ILVKLMEWEP
     GREEINAFSW SNSLQNTNIP HSAFISPKII NGKDVEEVSC IETQDNQNSE GEARNCCETS
     IRQDSDSSVS DKQRQTIIIA DSPSPAVSVI TISSDTDEEE TSQRHSLREC KGSLDCEACQ
     STLNIDRMCS LSSPDSTLST SSSGQSSPSP CKRPNSMSDE EQESSCDTVD GSPTSDSSGH
     DSPFAESTFV EDTHENTELV SSADTETKPA VCSVVVPPVE LENGLNADEH MANTDSICQP
     LIKGRSAPGR LNQPSAVGTR QQKLTSAFQQ QHLNFSQVQH FGSGHQEWNG NFGHRRQQAY
     IPTSVTSNPF TLSHGSPNHT AVHAHLAGNT HLGGQPTLLP YPSSATLSSA APVAHLLASP
     CTSRPMLQHP TYNISHPSGI VHQVPVGLNP RLLPSPTIHQ TQYKPIFPPH SYIAASPAYT
     GFPLSPTKLS QYPYM
//
